Honoring our roots, caring for our community.

Peptide therapy

Peptide & Wellness Therapies

Some peptide medications are FDA-approved for specific conditions; many others are investigational. Your provider explains which options, if any, are appropriate for you.

Evidence-based care Individualized plan
Peptides

Introduction

Individualized peptide and wellness care

Peptides are short chains of amino acids. Some are approved prescription medications for specific conditions, while many compounds promoted as "peptides" have not been approved by the FDA and lack established safety and effectiveness. Harmony evaluates every request individually and offers only options a licensed provider considers appropriate and lawful.

The options described on this page are not interchangeable. They differ in regulatory status, approved uses, available evidence and risks. A licensed provider reviews your health history, goals and medications before discussing whether any option is appropriate for you, and not everyone is a candidate.

Treatment categories

Different categories, different evidence

These products are not equivalent. Each category has its own regulatory status and safety considerations.

GLP-1 medications

Semaglutide, tirzepatide (GIP and GLP-1) and liraglutide. Brand-name products are FDA-approved for specific indications, such as type 2 diabetes or chronic weight management. Compounded versions are not FDA-approved. A provider decides whether you are eligible.

Approved for one specific indication

PT-141 (bremelanotide, Vyleesi®) is approved for acquired, generalized hypoactive sexual desire disorder in premenopausal women. Tesamorelin (Egrifta®) is approved to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. Other uses are not approved.

Investigational compounds

MOTS-c, injectable GHK-Cu, BPC-157, ipamorelin, Semax and Epithalon are not FDA-approved, and evidence in humans is limited. Sermorelin was previously approved but is no longer marketed. They are not routine treatments and are discussed only within an individual evaluation, where lawful and appropriate.

Not a peptide: methylene blue

A prescription medication FDA-approved to treat acquired methemoglobinemia. Wellness uses are investigational, and it can interact seriously with some antidepressants and other serotonergic medications.

Medical Weight Management

Semaglutide and tirzepatide

These GLP-1 medications are offered through Harmony's Medical Weight Management program, as part of a provider-supervised plan.

Semaglutide

A GLP-1 receptor agonist. Brand-name products are FDA-approved for specific indications. Prescribed only within a provider-supervised weight management plan.

View in Medical Weight Management

Tirzepatide

A dual GIP and GLP-1 receptor agonist. Brand-name products are FDA-approved for specific indications. Prescribed only within a provider-supervised weight management plan.

View in Medical Weight Management

Evaluation

How treatment is evaluated

No treatment is started without a medical evaluation.

01

Consultation

A visit with a licensed provider to discuss your goals and whether any option is appropriate.

02

Health history

Your goals, conditions, medications and prior treatments.

03

Eligibility and contraindications

Your provider screens for conditions, medications and other factors that make an option unsafe or inappropriate.

04

Laboratory testing

Baseline labs when clinically indicated.

05

Regulatory review

Your provider explains approval status, evidence and risks.

06

Follow-up

Monitoring and adjustment when a treatment is prescribed.

Safety

Safety & important information

Not all compounds listed in wellness catalogs are FDA-approved. Investigational uses lack established safety and efficacy. Use only under the supervision of a licensed healthcare provider.

FDA-approved medications are approved for specific indications. Any other use is off-label and is decided case by case by your provider.

Investigational compounds are not FDA-approved, and their safety and effectiveness are not established. Harmony does not offer them as routine treatments.

Compounded products are not FDA-approved, and their quality can vary. Some of these substances are prohibited in competitive sports.

Tell your provider if any of the following apply to you:

  • Pregnancy or breastfeeding (consult your provider)
  • Active cancer or a history of cancer
  • Uncontrolled diabetes or significant chronic illness
  • Children and adolescents under 18
  • All current medications and supplements are reviewed for interactions

FAQ

Peptide therapy FAQs

Clear answers to help you prepare.

Some peptide medications are approved for specific conditions. Many compounds marketed as peptides are not approved and are considered investigational. Your provider will tell you the status of any option discussed.

No. Methylene blue is a prescription medication, not a peptide. It is FDA-approved to treat acquired methemoglobinemia; other uses are investigational.

Not necessarily. Each entry describes a substance and its regulatory status. Whether any option is appropriate, and available, is decided only after an individual evaluation. Investigational compounds are not offered as routine treatments.

They are offered through Harmony's Medical Weight Management program, as part of a provider-supervised plan. This page links to them for reference.

These effects have not been established in reliable human studies, and some of these substances are prohibited in competitive sports. Your provider can explain what the current evidence does and does not show.

Next step

Have questions about peptide therapy?

Every plan starts with a medical evaluation by a licensed provider.

Request a consultation

Information on this page is educational and does not replace medical evaluation. Treatment options are determined individually.